AngioDynamics to buy electroporation tumour ablation firm Oncobionic
This article was originally published in Clinica
Executive Summary
AngioDynamics has signed a deal to acquire Oncobionic, a firm developing electroporation technology to treat tumours, for up to $25m. The two companies became partners in 2004.